Tonix and X-Chem collaborate to accelerate broad-spectrum antiviral development
Oct. 9, 2024
Tonix Pharmaceuticals Holding Corp. has entered into an artificial Intelligence and machine learning research collaboration with X-Chem Inc. to accelerate development of Tonix’s oral broad-spectrum antivirals for medical countermeasures.